Efficacy and Safety of Individualized Schedule of Sunitinib by Drug Monitoring in Patients with Metastatic Renal Cell Carcinoma

Efficacy and Safety of Individualized Schedule of Sunitinib by Drug Monitoring in Patients with Metastatic Renal Cell Carcinoma

Xudong Zhu,1,2,* Xingming Zhang,1,2,* Guangxi Sun,1,2,* Zhenhua Liu,1,2,* Haoran Zhang,1,2 Yaojing Yang,1,2 Yuchao Ni,1,2 Jindong Dai,1,2 Sha Zhu,1,2 Junru Chen,1,2 Jinge Zhao,1,2 Zhipeng Wang,1,2 Hao Zeng,1,2 Pengfei Shen1,2 1Department of Urology, West China Hospita...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Zhu X, Zhang X, Sun G, Liu Z, Zhang H, Yang Y, Ni Y, Dai J, Zhu S, Chen J, Zhao J, Wang Z, Zeng H, Shen P
פורמט: Article
שפה:English
יצא לאור: Dove Medical Press 2021-08-01
סדרה:Cancer Management and Research
נושאים:
sunitinib
plasma concentration
metastatic renal cell carcinoma
individualized schedule adjustment
clinical outcomes
גישה מקוונת:https://www.dovepress.com/efficacy-and-safety-of-individualized-schedule-of-sunitinib-by-drug-mo-peer-reviewed-fulltext-article-CMAR

אינטרנט

https://www.dovepress.com/efficacy-and-safety-of-individualized-schedule-of-sunitinib-by-drug-mo-peer-reviewed-fulltext-article-CMAR

פריטים דומים